Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Stock Forecast

RCKT's stock price has decreased by -75.55% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 13 professional analysts, the 12-month price target for Rocket Pharmaceuticals stock ranges from a low of $2.50 to a high of $263. The average analyst price target of $29.12 forecasts a 777.11% increase in the stock price over the next year.

Price Target: $29.12 (+777.11%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.50	$29.12	$8.00	$263
Change	-24.70%	+777.11%	+140.96%	+7821.7%

Analyst Ratings

The average analyst rating for Rocket Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	4	4	4	4
Buy	3	3	3	3	3	3
Hold	6	6	6	6	6	6
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Zemansky B of A Securities	B of A Securities	Strong Buy Maintains $10 → $8	Strong Buy	Maintains	$10 → $8	+140.96%	Nov 18, 2025
Tessa Romero JP Morgan	JP Morgan	Buy → Sell Downgrades $261 → $263	Buy → Sell	Downgrades	$261 → $263	+7,821.69%	Nov 18, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $11	Strong Buy	Maintains	$11	+231.33%	Oct 14, 2025
Mani Foroohar Leerink Partners	Leerink Partners	Hold Maintains $9 → $7	Hold	Maintains	$9 → $7	+110.84%	Oct 3, 2025
Jason Zemansky B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $4 → $10	Hold → Strong Buy	Upgrades	$4 → $10	+201.20%	Aug 20, 2025

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  19.49M
• EPS This Year:
  -2.13

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	19.49M
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.52	-2.67	-3.26	-2.92	-2.73	-2.13	-1.60
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	n/a	150.2M
Avg	n/a	19.5M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-2.05	-1.37
Avg	-2.13	-1.60
Low	-2.25	-1.79

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.